QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 citigroup-maintains-neutral-on-sight-sciences-lowers-price-target-to-4

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and lowers the price target from $4.5...

 unitedhealthcare-adds-sight-sciences-omni-system-to-covered-glaucoma-surgery-procedures

UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate o...

 needham-reiterates-hold-on-sight-sciencesto-hold

Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) from Hold to Hold.

 citigroup-maintains-neutral-on-sight-sciences-raises-price-target-to-45

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3.6...

 lake-street-upgrades-sight-sciences-to-buy-raises-price-target-to-5

Lake Street analyst Frank Takkinen upgrades Sight Sciences (NASDAQ:SGHT) from Hold to Buy and raises the price target from $...

 sight-sciences-raises-fy2025-sales-guidance-from-70000m-75000m-to-72000m-76000m-vs-72431m-est

Sight Sciences (NASDAQ:SGHT) raises FY2025 sales outlook from $70.000 million-$75.000 million to $72.000 million-$76.000 millio...

 sight-sciences-q2-eps-023-beats-029-estimate-sales-19564m-beat-18183m-estimate

Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29...

 sight-sciences-study-finds-tearcare-more-effective-and-cheaper-than-cyclosporine-for-dry-eye-relief

Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and com...

 morgan-stanley-maintains-equal-weight-on-sight-sciences-raises-price-target-to-4

Morgan Stanley analyst Cecilia Furlong maintains Sight Sciences (NASDAQ:SGHT) with a Equal-Weight and raises the price targe...

 piper-sandler-maintains-neutral-on-sight-sciences-raises-price-target-to-4

Piper Sandler analyst Adam Maeder maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3....

 citigroup-maintains-neutral-on-sight-sciences-raises-price-target-to-36

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3.2...

 lake-street-maintains-hold-on-sight-sciences-raises-price-target-to-3

Lake Street analyst Frank Takkinen maintains Sight Sciences (NASDAQ:SGHT) with a Hold and raises the price target from $2.5 ...

 sight-sciences-affirms-fy2025-sales-guidance-of-7000m-7500m-vs-7213m-est

Sight Sciences (NASDAQ:SGHT) affirms FY2025 sales outlook from $70.00 million-$75.00 million to $70.00 million-$75.00 million v...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION